Adenocarcinoma With Squamous Metaplasia of the Gallbladder
2 clinical trials · Condition
◉ Watch Adenocarcinoma With Squamous Metaplasia of the Gallbladder
| Record | Firm | Date |
|---|---|---|
| Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182) | National Cancer Institute (NCI) | 2013-01-01 |
| S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT00238212) | National Cancer Institute (NCI) | 2005-10-01 |
Track Adenocarcinoma With Squamous Metaplasia of the Gallbladder automatically
Every clearance here is in the API, with alerts when new ones post.